This is the Scientific Surgery Archive, which contains all randomized clinical trials in surgery that have been identified by searching the top 50 English language medical journal issues since January 1998. Compiled by Jonothan J. Earnshaw, former Editor-in-Chief, BJS
Experience of surgery for rectal cancer with total mesorectal excision in a general surgical practice. BJS 2002; 89: 1014-1019.
Published: 29th November 2002
Authors: J. F. Dowdall, D. Maguire, O. J. McAnena
Background
Results from specialist centres have shown that total mesorectal excision (TME) produces excellent control of local disease in patients with carcinoma of the rectum.
Method
The results of TME were reviewed in a surgical practice in which patients with rectal cancer comprised 1 per cent of the total caseload and mean case numbers were less than 15 each year.
Results
Eighty‐two consecutive patients underwent rectal excision with TME over a 72‐month period (68 anterior resection, eight abdominoperineal excision and six Hartmann's procedure). Sixty‐nine operations were deemed ‘curative’ at the time of surgery. Anastomotic leak occurred in two (3 per cent) of 68 patients, both of whom recovered without additional surgery. There were two local recurrences (3 per cent) among 69 patients who underwent ‘curative’ surgery. At a median follow‐up of 190 weeks, the survival rate for Dukes' stage A, B, C and ‘D’ was 100, 83, 68 and 18 per cent respectively.
Conclusion
Outcome as measured by perioperative morbidity and local disease control achieved in a surgical practice with a broad case mix and relatively low annual case volume was comparable to that from larger centres. Appropriate surgical training and attention to technical detail may be as important as case volume in determining outcome after surgery for rectal cancer. © 2002 British Journal of Surgery Society Ltd
Full text